Eiger BioPharmaceuticals, Inc. 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Nov 21, 2016
Insider Transaction Report
Form 4
Glenn Jeffrey S
Director
Transactions
- Purchase
Common Stock
2016-11-18$12.90/sh+460$5,934→ 460 total(indirect: By son) - Purchase
Common Stock
2016-11-17$12.73/sh+15,000$190,950→ 16,355 total
Holdings
- 151,064(indirect: See footnote)
Common Stock
Footnotes (1)
- [F1]Shares are held by Eiger Group International, Inc. ("EGI"). The Reporting Person is the Chief Executive Officer of EGI and has sole power to vote and sole power to dispose of shares directly owned by EGI. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.